Q/C Technologies, Inc. (QCLS) bonds
QCLSNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.31−0.03 (-8.29%)
Close on Nov 18, 2026Market cap $2.51MP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Q/C Technologies reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in Q/C Technologies's 10-K for the period ended May 31, 2019
Q/C Technologies's filings do not break debt down by note
The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size |
|---|---|
| Revolving Credit Facility | $5.00M |
See a number that looks wrong?